Tirzepatide is a synthetic peptide designed as a dual agonist: it addresses the receptor of the incretin hormone GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 receptor at the same time. The linear peptide is built from 39 amino acids and carries – as other modern incretin analogues do – a fatty diacid side chain attached via a linker, which stabilises the molecule against rapid enzymatic degradation.
Structurally, tirzepatide follows the GIP sequence but contains targeted modifications that enable binding to both receptor types. The molecule therefore stands as an example of a newer generation of so-called multi-receptor agonists in peptide chemistry. As an active substance, tirzepatide is a component of prescription medicines; in the context described here, the subject is exclusively tirzepatide as a reference and research material for the laboratory.
Profile
Molecule type: synthetic linear peptide with fatty diacid side chain (lipidated)
Number of amino acids: 39
Substance class (pharmacological classification): dual GIP/GLP-1 receptor agonist
Research classification: reference and research material, Research Use Only (RUO)
Research context
In the scientific literature, tirzepatide is examined above all in basic metabolic research. Central topics are the pharmacology of dual receptor agonists – that is, the question of how a single molecule binds to two different incretin receptors and which signalling pathways are activated in cell models – along with structure-activity relationships within the incretin peptide family.
Tirzepatide is also a frequent subject of analytical chemistry: methods for quantifying lipidated peptides, stability studies and comparative analyses use the substance as a model or reference material. Preclinical work on energy and glucose metabolism in animal models has likewise been published. All of this is summarised here in neutral terms; it describes the state of research and makes no statement about use in humans.
Quality criteria for laboratory procurement
For a lipidated peptide 39 amino acids long, synthesis is demanding – which makes quality documentation correspondingly important. A complete certificate of analysis (COA) states HPLC purity and confirms by mass spectrometry that sequence length and side-chain modification are present as specified. Every batch requires a unique number linking the label to the test report.
Storage follows the rules for sensitive research peptides: the lyophilised material is kept dry, protected from light and cool, and frozen for longer periods. Temperature cycling and moisture ingress are the main risks to material integrity and should be avoided by organisational means, for instance by preparing aliquots.
Frequently asked questions
Is tirzepatide legal as a research material?
Obtaining tirzepatide as a research and reference material for scientific laboratory purposes is legal. This must be clearly separated from approved medicines containing the active substance tirzepatide: those are subject to prescription and are dispensed exclusively through pharmacies. Research material is excluded from any use in humans.
What should be checked on the COA?
Three elements: batch-level traceability, an HPLC purity figure and mass-spectrometric confirmation of identity. For a complex modified molecule such as tirzepatide, the mass confirmation is particularly informative, because it makes synthesis errors and missing modifications visible.
How is tirzepatide stored?
As a lyophilised solid, dry, dark and cool – frozen for long-term storage. In laboratory practice it has proven useful to divide material into single portions so that the stock is not repeatedly exposed to temperature fluctuations.
Available at Peptélia
Peptélia offers tirzepatide as a research material with a batch-specific certificate of analysis (COA). The available products can be found in the Tirzepatide category at Peptélia.
Important notice
All substances offered by Peptélia are intended exclusively for scientific use in the laboratory (Research Use Only). They are not medicines, not food supplements and not cosmetics. Use in humans or animals, as well as any diagnostic or therapeutic use, is expressly excluded.
Distinction from approved medicines: tirzepatide is the active substance of prescription medicines such as Mounjaro. Peptélia does not distribute such medicines. This article serves scientific information purposes only and is neither a procurement nor a usage guide.
For research use only. Not for use in or on the human body.
